Rein Therapeutics, Inc.
Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.
RNTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00887A2042 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 12407 N. MOPAC EXPY., 78758 AUSTIN
- Website:
- https://www.reintx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Rein Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines. The company is focused on developing therapies to address significant unmet medical needs in orphan pulmonary diseases and fibrosis, such as Idiopathic Pulmonary Fibrosis (IPF). Its stated goal is to improve lung function, minimize side effects, and enhance the quality of life for patients with these conditions. The company was formerly known as Aileron Therapeutics Inc.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Rein Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Rein Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Rein Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
